503 research outputs found
New roles and global agents in information organization in libraries
[Resumen]
En un nuevo escenario globalizado, los roles de los agentes tradicionales de la organización de la
información en bibliotecas han tendido a converger con aquellos provenientes de la industria del libro,
bajo la presunción de que en su mayor parte las prácticas tradicionales bibliotecarias no son válidas ante
esta nueva situación. El presente trabajo analiza la naturaleza e implicaciones para las bibliotecas de los
vínculos existentes entre los agentes provenientes de la industria de libro y los organismos responsables de
los principales sistemas de organización de la información bibliotecarios, tanto en un ámbito internacional
como en el caso concreto de España. Algunos de los agentes cuyos discursos han sido analizados incluyen
OCLC, el Consorcio de la CDU, BISG, BIC, EDItEUR, DILVE, Google y Amazon, concluyéndose que
existe una incursión y colaboración entre uno y otro sector que se materializará en un aumento de la
universalidad y homogeneización de unas prácticas de organización de la información en bibliotecas en las que no se tienen en cuenta la naturaleza y características específicas de las diferentes comunidades y
contextos.[Abstract]
In a new globalized scenario, the traditional activities of information organisation agents in libraries
have tended to converge with those from the book industry, under the presumption that most traditional
library practices are not adequate for the new globalized situation. This article analyzes the nature and
consequences for libraries of the links between agents from the book industry and the organizations
in charge of the main library information organization systems, both at an international level and in
Spain. Some of the agents whose discourses were analyzed include OCLC, the UDC Consortium, BISG,
BIC, EDItEUR, DILVE, Google and Amazon. We conclude that there is evidence of an incursion of
book industry practices into the information organisation practices of OCLC and that collaboration
between both sectors will result in an increase in universality and homogenization in library information
organization practices without consideration for the nature and specific characteristics of the library and
how it differs from the bookstore
A Leptin-regulated Circuit Controls Glucose Mobilization During Noxious Stimuli
Adipocytes secrete the hormone leptin to signal the sufficiency of energy stores. Reductions in circulating leptin concentrations reflect a negative energy balance, which augments sympathetic nervous system (SNS) activation in response to metabolically demanding emergencies. This process ensures adequate glucose mobilization despite low energy stores. We report that leptin receptor–expressing neurons (LepRb neurons) in the periaqueductal gray (PAG), the largest population of LepRb neurons in the brain stem, mediate this process. Application of noxious stimuli, which often signal the need to mobilize glucose to support an appropriate response, activated PAG LepRb neurons, which project to and activate parabrachial nucleus (PBN) neurons that control SNS activation and glucose mobilization. Furthermore, activating PAG LepRb neurons increased SNS activity and blood glucose concentrations, while ablating LepRb in PAG neurons augmented glucose mobilization in response to noxious stimuli. Thus, decreased leptin action on PAG LepRb neurons augments the autonomic response to noxious stimuli, ensuring sufficient glucose mobilization during periods of acute demand in the face of diminished energy stores
Nicotine Bitartrate Reduces Falls and Freezing of Gait in Parkinson Disease: A Reanalysis
Objective: Determine if NC001, an oral formulation of nicotine that reduces levodopa-induced dyskinesias (LIDs) in MPTP-Parkinson monkeys, could reduce falls, freezing of gait (FOG), and LIDs in Parkinson disease (PD) patients. Methods: Previously collected data from a study analyzing the effects of NC001 on LIDs in PD patients were reanalyzed. Because indirect-acting cholinergic drugs are sometimes helpful in reducing falls, we hypothesized that NC001, a direct-acting cholinergic agonist, could reduce falls in PD. The original 12-center, double-blind, randomized trial enrolled 65 PD patients. NC001 or placebo was administered 4 times per day for 10 weeks, beginning at 4 mg/day and escalating to 24 mg/day. Assessments included the Unified Dyskinesia Rating Scale (UDysRS) and Parts II-III of the original Unified Parkinson\u27s Disease Rating Scale (UPDRS). Results: Randomization (1:1) resulted in 35 patients on NC001 and 30 on placebo at baseline. Thirty and 27 patients, respectively, had data available for an intent-to-treat analysis. NC001 was safe and well-tolerated. After 10 weeks, NC001 patients (14/30) had a significant reduction in falls vs. placebo patients (3/27) (p = 0.0041) as assessed by UPDRS Part II. NC001 patients (12/30) also had significantly reduced FOG vs. placebo patients (4/27) (p = 0.0043). NC001 patients, compared with placebo patients, had a significant improvement (p = 0.01) in UDysRS ambulation subtest (40% vs. 3%, respectively). Although NC001 patients had a greater reduction in dyskinesias on the UDysRS than placebo patients (30% vs. 19%, respectively), this was not significant (p = 0.09). Conclusions: NC001 significantly improved two refractory symptoms of PD, falls and FOG. The reduction in falls and FOG is attributed to selective stimulation of nicotinic receptors
Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis
L-selectin ligands might be relevant for inflammatory cell trafficking into the small intestine in a spontaneous model of chronic ileitis (i.e., SAMP1/YitFc mice). Immunoblockade of peripheral node addressin or mucosal addressin cell adhesion molecule 1 failed to ameliorate ileitis, whereas P-selectin glycoprotein ligand 1 (PSGL-1) neutralization attenuated both the adoptively transferred and spontaneous disease. PSGL-1 was detected in venules of mesenteric lymph node and small intestine by immunohistochemistry and confirmed by real-time reverse transcription polymerase chain reaction and flow cytometry. In addition, reconstitution of wild-type mice with PSGL-1−/− bone marrow demonstrated that PSGL-1 messenger RNA and PSGL-1 protein expression remained on endothelium, localized within mesenteric lymph node and small intestine. Endothelial PSGL-1 bound P-selectin–IgG and its blockade or genetic deletion altered the recruitment of lymphocytes to the small intestine, as revealed by intravital microscopy and homing studies. Endothelial expression of PSGL-1 adds a new dimension to the various cellular interactions involved in small intestinal recruitment. Thus, the multiple roles of PSGL-1 may explain why targeting this single adhesion molecule results in attenuation of chronic murine ileitis, a disease previously resistant to antiadhesion molecule strategies
Mutations in Ribonucleic Acid Binding Protein Gene Cause Familial Dilated Cardiomyopathy
ObjectivesWe sought to identify a novel gene for dilated cardiomyopathy (DCM).BackgroundDCM is a heritable, genetically heterogeneous disorder that remains idiopathic in the majority of patients. Familial cases provide an opportunity to discover unsuspected molecular bases of DCM, enabling pre-clinical risk detection.MethodsTwo large families with autosomal-dominant DCM were studied. Genome-wide linkage analysis was used to identify a disease locus, followed by fine mapping and positional candidate gene sequencing. Mutation scanning was then performed in 278 unrelated subjects with idiopathic DCM, prospectively identified at the Mayo Clinic.ResultsOverlapping loci for DCM were independently mapped to chromosome 10q25-q26. Deoxyribonucleic acid sequencing of affected individuals in each family revealed distinct heterozygous missense mutations in exon 9 of RBM20, encoding ribonucleic acid (RNA) binding motif protein 20. Comprehensive coding sequence analyses identified missense mutations clustered within this same exon in 6 additional DCM families. Mutations segregated with DCM (peak composite logarithm of the odds score >11.49), were absent in 480 control samples, and altered residues within a highly conserved arginine/serine (RS)-rich region. Expression of RBM20 messenger RNA was confirmed in human heart tissue.ConclusionsOur findings establish RBM20as a DCM gene and reveal a mutation hotspot in the RS domain. RBM20is preferentially expressed in the heart and encodes motifs prototypical of spliceosome proteins that regulate alternative pre-messenger RNA splicing, thus implicating a functionally distinct gene in human cardiomyopathy. RBM20mutations are associated with young age at diagnosis, end-stage heart failure, and high mortality
Health gains and fi nancial risk protection aff orded by public fi nancing of selected interventions in Ethiopia: an extended cost-eff ectiveness analysis
Background The way in which a government chooses to fi nance a health intervention can aff ect the uptake of health
interventions and consequently the extent of health gains. In addition to health gains, some policies such as public
fi nance can insure against catastrophic health expenditures. We aimed to evaluate the health and fi nancial risk
protection benefi ts of selected interventions that could be publicly fi nanced by the government of Ethiopia.
Methods We used extended cost-eff ectiveness analysis to assess the health gains (deaths averted) and fi nancial risk
protection aff orded (cases of poverty averted) by a bundle of nine (among many other) interventions that the
Government of Ethiopia aims to make universally available. These nine interventions were measles vaccination,
rotavirus vaccination, pneumococcal conjugate vaccination, diarrhoea treatment, malaria treatment, pneumonia
treatment, caesarean section surgery, hypertension treatment, and tuberculosis treatment.
Findings Our analysis shows that, per dollar spent by the Ethiopian Government, the interventions that avert the most
deaths are measles vaccination (367 deaths averted per 100 000 spent), and caesarean section surgery (141 deaths averted per 100 000 spent), tuberculosis
treatment (96 cases averted per 100 000 spent).
Interpretation Our approach incorporates fi nancial risk protection into the economic evaluation of health interventions
and therefore provides information about the effi ciency of attainment of both major objectives of a health system:
improved health and fi nancial risk protection. One intervention might rank higher on one or both metrics than
another, which shows how intervention choice—the selection of a pathway to universal health coverage—might
involve weighing up of sometimes competing objectives. This understanding can help policy makers to select
interventions to target specifi c policy goals (ie, improved health or fi nancial risk protection). It is especially relevant
for the design and sequencing of universal health coverage to meet the needs of poor populations
- …